Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities

Sung-Whan Kim; Hong-Zhe Zhang; Longzhe Guo; Jong-Min Kim; Moo Hyun Kim
July 2012
PLoS ONE;Jul2012, Vol. 7 Issue 7, p1
Academic Journal
Although human amniotic mesenchymal stem cells (AMMs) have been recognised as a promising stem cell resource, their therapeutic potential for wound healing has not been widely investigated. In this study, we evaluated the therapeutic potential of AMMs using a diabetic mouse wound model. Quantitative real-time PCR and ELISA results revealed that the angiogenic factors, IGF-1, EGF and IL-8 were markedly upregulated in AMMs when compared with adipose-derived mesenchymal stem cells (ADMs) and dermal fibroblasts. In vitro scratch wound assays also showed that AMM-derived conditioned media (CM) significantly accelerated wound closure. Diabetic mice were generated using streptozotocin and wounds were created by skin excision, followed by AMM transplantation. AMM transplantation significantly promoted wound healing and increased re-epithelialization and cellularity. Notably, transplanted AMMs exhibited high engraftment rates and expressed keratinocyte-specific proteins and cytokeratin in the wound area, indicating a direct contribution to cutaneous closure. Taken together, these data suggest that AMMs possess considerable therapeutic potential for chronic wounds through the secretion of angiogenic factors and enhanced engraftment/differentiation capabilities.


Related Articles

  • Human adipose-derived stem cells cultured in keratinocyte serum free medium: Donor's age does not affect the proliferation and differentiation capacities. Dah-Ching Ding; Hsiang-Lan Chou; Wei-Ting Hung; Hwan-Wun Liu; Tang-Yuan Chu // Journal of Biomedical Science;2013, Vol. 20 Issue 1, p1 

    Background: Although donor age-related effects of characteristics of mesenchymal stem cells (MSC), such as a decrease in the proliferation and differentiation capacity and an increase of senescence and apoptosis, are evident, such effects are generally less prominent in adipose-derived stem...

  • TGF-β/SMAD signaling regulation of mesenchymal stem cells in adipocyte commitment. Li, Sheng-Nan; Wu, Jia-Fa // Stem Cell Research & Therapy;1/29/2020, Vol. 11 Issue 1, p1 

    Adipocytes arising from mesenchymal stem cells (MSCs) requires MSC adipocyte commitment and differentiation of preadipocytes to mature adipocytes. Several signaling and some cytokines affect the adipogenesis of MSCs. This review focuses on the roles of TGF-β/SMAD signaling in adipocyte...

  • Research advances of fibroblastic differentiation of bone marrow mesenchymal stem cells. FU Hong-hai; HE Yue // China Journal of Oral & Maxillofacial Surgery;May2011, Vol. 9 Issue 3, p248 

    Bone marrow derived mesenchymal stem cells (BMSCs) can differentiate into multiple cell lineages such as osteoblasts, chondrocytes, and adipocytes. Furthermore, it is relatively easily harvested. So, it has wide applications in tissue engineering and regenerative medicine. Under a specific...

  • The elusive nature and function of mesenchymal stem cells. Nombela-Arrieta, César; Ritz, Jerome; Silberstein, Leslie E. // Nature Reviews Molecular Cell Biology;Feb2011, Vol. 12 Issue 2, p126 

    Mesenchymal stem cells (MSCs) are a diverse subset of multipotent precursors present in the stromal fraction of many adult tissues and have drawn intense interest from translational and basic investigators. MSCs have been operationally defined by their ability to differentiate into osteoblasts,...

  • Mouse Embryonic Fibroblasts (MEF) Exhibit a Similar but not Identical Phenotype to Bone Marrow Stromal Stem Cells (BMSC). Saeed, Hamid; Taipaleenmäki, Hanna; Aldahmash, Abdullah; Abdallah, Basem; Kassem, Moustapha // Stem Cell Reviews & Reports;Jun2012, Vol. 8 Issue 2, p318 

    Mouse embryonic fibroblasts have been utilized as a surrogate stem cell model for the postnatal bone marrow-derived stromal stem cells (BMSC) to study mesoderm-type cell differentiation e.g. osteoblasts, adipocytes and chondrocytes. However, no formal characterization of MEF phenotype has been...

  • Antioxidants cause rapid expansion of human adipose-derived mesenchymal stem cells via CDK and CDK inhibitor regulation. Li-Yi Sun; Cheng-Yoong Pang; Dian-Kun Li; Chia-Hsin Liao; Wei-Chao Huang; Chao-Chuan Wu; Yi-Yo Chou; Wei Wu Li; Shin-Yuan Chen; Hwan-Wun Liu; Yao-Jen Chang; Ching-Feng Cheng // Journal of Biomedical Science;2013, Vol. 20 Issue 1, p1 

    Background: Antioxidants have been shown to enhance the proliferation of adipose-derived mesenchymal stem cells (ADMSCs) in vitro, although the detailed mechanism(s) and potential side effects are not fully understood. In this study, human ADMSCs cultured in ImF-A medium supplemented with...

  • Generation of high-yield insulin producing cells from human bone marrow mesenchymal stem cells. Jafarian, Arefeh; Taghikhani, Mohammad; Abroun, Saeid; Pourpak, Zahra; Allahverdi, Amir; Soleimani, Masoud // Molecular Biology Reports;Jul2014, Vol. 41 Issue 7, p4783 

    Allogenic islet transplantation is a most efficient approach for treatment of diabetes mellitus. However, the scarcity of islets and long term need for an immunosuppressant limits its application. Recently, cell replacement therapies that generate of unlimited sources of β cells have been...

  • Recent Developments in β-Cell Differentiation of Pluripotent Stem Cells Induced by Small and Large Molecules. Kumar, S. Suresh; Alarfaj, Abdullah A.; Munusamy, Murugan A.; Singh, A. J. A. Ranjith; I-Chia Peng; Priya, Sivan Padma; Hamat, Rukman Awang; Higuchi, Akon // International Journal of Molecular Sciences;2014, Vol. 15 Issue 12, p23418 

    Human pluripotent stem cells, including human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), hold promise as novel therapeutic tools for diabetes treatment because of their self-renewal capacity and ability to differentiate into beta (β)-cells. Small and large...

  • Brief Report: The Differential Roles of m TORC1 and m TORC2 in Mesenchymal Stem Cell Differentiation. Martin, Sally K.; Fitter, Stephen; Dutta, Ankit K.; Matthews, Mary P.; Walkley, Carl R.; Hall, Michael N.; Ruegg, Markus A.; Gronthos, Stan; Zannettino, Andrew C. W. // Stem Cells (Wiley-Blackwell);Apr2015, Vol. 33 Issue 4, p1359 

    Adipocytes (AdCs) and osteoblasts (OBs) are derived from mesenchymal stem cells (MSCs) and differentiation toward either lineage is both mutually exclusive and transcriptionally controlled. Recent studies implicate the mammalian target of rapamycin (mTOR) pathway as important in determining MSC...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics